Trials / Completed
CompletedNCT01373255
Balloon Catheters in Cases of Abnormal Placentation
Balloon Catheter for Occlusion of the Pelvic Vasculature as an Adjuvant Therapy in Cases of Placenta Accreta
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- HaEmek Medical Center, Israel · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Placenta accreta is a relatively rare event, in which the placenta is abnormally implanted into the uterine myometrium. The most significant complication is intense bleeding, mainly during labor. The most important risk factors are previous cesarean delivery, placenta previa, and advanced maternal age. Cesarean hysterectomy is the recommended management. During the recent years, inserting intravascular balloon catheter for occlusion and/or arterial embolization, was introduced as an adjuvant therapy in order to minimize blood loss during cesarean hysterectomy or in conduct with conservative management with the intent of avoiding hysterectomy in selective cases. Contradicting reports exist regarding the effectiveness and safety of the catheters in cases of placenta accreta. The objective of this study is to estimate the efficacy of the balloon catheters among women diagnosed with a placenta accreta.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | internal iliac catheterization | Women in this arm will undergo internal iliac artery catheterization prior to the cesarean delivery |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2011-06-14
- Last updated
- 2015-06-16
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01373255. Inclusion in this directory is not an endorsement.